Trial Profile

Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
Indications Hyperphosphataemia; Renal failure
Focus Therapeutic Use
Acronyms LAVALIER

Most Recent Events

24 Feb 2021 Planned End Date changed from 31 Mar 2023 to 1 Sep 2023.
24 Feb 2021 Planned primary completion date changed from 1 Dec 2020 to 31 Mar 2023.
13 Jan 2021 Planned End Date changed from 1 Jun 2021 to 31 Mar 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com